Stocks and Investing Stocks and Investing
Fri, October 4, 2019
Thu, October 3, 2019

Alethia Young Maintained (ANAB) at Hold with Decreased Target to $48 on, Oct 3rd, 2019


Published on 2024-10-26 16:36:31 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Credit Suisse, Maintained "AnaptysBio, Inc." (ANAB) at Hold with Decreased Target from $75 to $48 on, Oct 3rd, 2019.

Alethia has made no other calls on ANAB in the last 4 months.



There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 1 agrees with Alethia's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • M. Auster of "Credit Suisse" Maintained at Hold with Decreased Target to $75 on, Friday, August 9th, 2019


This is the rating of the analyst that currently disagrees with Alethia


  • Yatin Suneja of "SunTrust Robinson Humphrey" Maintained at Strong Buy with Decreased Target to $93 on, Monday, June 24th, 2019

Contributing Sources